BIOCONPharmaceuticals
Biocon Ltd — Quarterly Results & Earnings
₹360.90
-2.52%
Profit Growth YoY486.23%Latest quarter
Sales Growth YoY19.64%Latest quarter
Sales CAGR 5Y19.11%5 year compound
Profit CAGR 5Y7.16%5 year compound
📋
Quarterly Performance
YoY Profit Growth+486.23%
🔥 Exceptional growth
YoY Sales Growth+19.64%
✅ Strong growth
OPM 5Y Average
21.68%Operating profit margin
EPS Growth 5Y
7.15%Interest Coverage
1.90Higher = safer debt servicing
ROE
4.76%ROCE
6.25%💡
Growth Analysis
Biocon Ltd reported YoY profit growth of 486.23% and revenue growth of 19.64% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 19.11% and profits at 7.16% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Biocon Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.